Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.83 USD | -1.39% | +4.81% | +11.52% |
25/04 | OncoCyte Corporation announced that it has received $15.807655 million in funding | CI |
16/04 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.52% | 38.36M | |
+3.33% | 108B | |
+10.69% | 104B | |
+1.28% | 22.33B | |
-12.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.84% | 17.64B | |
+4.88% | 14.05B | |
+34.51% | 12.51B |
- Stock Market
- Equities
- OCX Stock
- News OncoCyte Corporation
- Needham Adjusts Price Target on OncoCyte to $3.60 From $4.25, Maintains Buy Rating